Literature DB >> 26989728

EBV seroepidemiology in married and unmarried women and men in Iran.

Morteza Pourahamad1, Farhang Hooshmand2, Sara Olyaee Nezhad3, Abdolali Sepidkar4.   

Abstract

BACKGROUND: Among the eight known human herpes viruses, Epstein- Barr virus (EBV) is considered to be sexually transmissible. This study was conducted to evaluate the seroepidemiology of this infection in married and unmarried Iranian couples.
METHODS: In this comparative observational and cross-sectional study, 160 men and women were divided into married and unmarried groups. Serum IgG and IgM antibodies to the EBV viral capsid antigen were analyzed by Enzyme-linked Immunosorbent Assays (ELISAs).
RESULTS: In this study 78 men and 82 women were enrolled. Ninety percent of the married and 76.2% of the unmarried women were anti-EBV IgG positive (P = 0.08), while 80% of the married and 94% of the unmarried men were antiEBV IgG positive (P = 0.052).
CONCLUSION: Seroepidemiology of EBV is not significantly different in married vs. unmarried women and men in Iran; therefore, sexual contact may not be the primary mechanism of EBV transmission in Iran and other developing countries. Attention to other possible routes of transmission is recommended.

Entities:  

Keywords:  Anti-VCA; Epstein Barr Virus; Sexual contact

Year:  2014        PMID: 26989728      PMCID: PMC4757053     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  19 in total

1.  Infectious mononucleosis.

Authors:  L E. Moffat
Journal:  Prim Care Update Ob Gyns       Date:  2001-03

2.  Excretion of the Epstein-Barr virus from the genital tract of men.

Authors:  V Israele; P Shirley; J W Sixbey
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Is Epstein-Barr virus transmitted sexually?

Authors:  Joseph S Pagano
Journal:  J Infect Dis       Date:  2007-01-10       Impact factor: 5.226

4.  Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.

Authors:  K M Myhr; T Riise; E Barrett-Connor; H Myrmel; C Vedeler; M Grønning; M B Kalvenes; H Nyland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

5.  Role of sexual behavior in the acquisition of asymptomatic Epstein-Barr virus infection: a longitudinal study.

Authors:  Ciaran B J Woodman; Stuart I Collins; Nicol Vavrusova; Ankit Rao; Jaap M Middeldorp; Zdenek Kolar; Angela Kumari; Paul Nelson; Lawrence S Young; Paul G Murray
Journal:  Pediatr Infect Dis J       Date:  2005-06       Impact factor: 2.129

6.  Comparative study of specific ebv antibodies between children manifest classic triad of mononucleosis with unaffected children in hazrat rasool akram hospital (1998-2000).

Authors:  Samile Noorbakhsh; A Siadati; Farzaneh Ashtiani; Setareh Mamishi; S Kooh Paiezadeh
Journal:  Iran J Allergy Asthma Immunol       Date:  2003-06       Impact factor: 1.464

7.  Infectious mononucleosis and mononucleosis-like illnesses in children and adults in Saudi Arabia.

Authors:  A Hossain
Journal:  J Trop Pediatr       Date:  1989-06       Impact factor: 1.165

8.  [Epstein-Barr virus antibodies in blood serum of patients with laryngeal cancer].

Authors:  Kamal Morshed; Małgorzata Polz-Dacewicz; Marcin Szymański; Marta Ziaja; Wiesław Gołabek
Journal:  Otolaryngol Pol       Date:  2002

9.  A second site for Epstein-Barr virus shedding: the uterine cervix.

Authors:  J W Sixbey; S M Lemon; J S Pagano
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

10.  Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines.

Authors:  E Lindhout; A Lakeman; M L Mevissen; C de Groot
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  1 in total

1.  Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature.

Authors:  Joanne R Winter; Charlotte Jackson; Joanna Ea Lewis; Graham S Taylor; Olivia G Thomas; Helen R Stagg
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.